Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-21

FDA Approved: NICOTINE POLACRILEX GUM — Original Application (Fertin Pharma A/S)

View source ↗

Summary

FDA approved Fertin Pharma A/S's Nicotine Polacrilex Gum as an original application for the treatment of nicotine dependence and to aid smoking cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine Polacrilex Gum (nicotine polacrilex)

Snippet

ORIG AP for NICOTINE POLACRILEX GUM (NICOTINE POLACRILEX)